Business expansion
Südösterreich; Steiermark;
Location of affected unit(s)
Graz, Werndorf
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.1 - Manufacture of basic pharmaceutical products

100 jobs
Number of planned job creations
Job creation
Announcement Date
5 July 2012
Employment effect (start)
5 July 2012
Foreseen end date
31 December 2015


Fresenius Kabi, a German pharmaceutical company, is to invest €34 million in its Graz sites, thus employing an additional 160 employees by 2015.

The company, which is specialised in infusion therapy, is to develop four new product lines at its Graz and Wernberg (just south of Graz) sites. According to Mr Haszonits, the company's CEO, some 60 positions have already been filled, with more to be filled in the areas logistics and production (product management), as well as project management and controlling. The so-called 'finalising area' which encompasses the packaging and labelling of the products is to move to the logistics centre Wernberg. The expansion is due to increases in turnover.

By the end of 2012, some 100 out of the envisaged 160 positions will be filled.


  • 5 July 2012: Wirtschaftsblatt
  • 5 July 2012: orf.at


Eurofound (2012), Fresenius Kabi, Business expansion in Austria, factsheet number 73847, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/73847.